Follow us on Twitter
twitter icon@FreshPatents


Cardiac Arrhythmia patents

      

This page is updated frequently with new Cardiac Arrhythmia-related patent applications.




 Water resistant wearable medical device patent thumbnailWater resistant wearable medical device
A wearable medical device includes a water-resistant/waterproof housing configured to be continuously or nearly continuously worn by a patient and formed from a water-resistant/waterproof material, and configured to prevent ingress of water in a wet environment; a plurality of ecg sensing electrodes configured to be removably coupled to the patient and to monitor an ecg of the patient; a plurality of therapy electrodes configured to be removably coupled to the patient and to deliver at least one therapeutic pulse to the patient; and a control unit disposed within the water-resistant/waterproof housing and configured to be electrically coupled to the plurality of ecg sensing electrodes and the plurality of therapy electrodes, the control unit configured to receive the monitored ecg of the patient, and responsive to detection of a cardiac arrhythmia, provide the at least one therapeutic pulse to the patient via the at least one therapy electrode.. .
Zoll Medical Corporation


 Systems and methods for leadless pacing and shock therapy patent thumbnailSystems and methods for leadless pacing and shock therapy
Techniques and systems for monitoring cardiac arrhythmias and delivering electrical stimulation therapy using a subcutaneous implantable cardioverter defibrillator (sicd) and a leadless pacing device (lpd) are described. For example, the sicd may detect a tachyarrhythmia within a first electrical signal from a heart and determine, based on the tachyarrhythmia, to deliver anti-tachyarrhythmia shock therapy to the patient to treat the detected arrhythmia.
Medtronic, Inc.


 Novel cyp-eicosanoid derivatives patent thumbnailNovel cyp-eicosanoid derivatives
The present invention relates to compounds according to general formula (i) which are analogues of epoxymetabolites produced by cytochrome p450 (cyp) enzymes from omega-3 (n-3) polyunsaturated fatty acids (pufas). The present invention further relates to compositions containing one or more of these compounds and to the use of these compounds or compositions for c the treatment or prevention of conditions and diseases associated with inflammation, proliferation, hypertension, coagulation, immune function, pathologic angiogenesis, heart failure and cardiac arrhythmias..
Board Of Regents, The University Of Texas System


 Short acting phenylalkylamine calcium channel blockers and uses thereof patent thumbnailShort acting phenylalkylamine calcium channel blockers and uses thereof
The present invention relates to the use of a pharmaceutically effective amount of an short-acting calcium channel blocking compound to treat ischemic heart conditions, cardiac arrhythmias, hypertensive crisis in an emergency room setting, hypertension before, during, or after surgery, no-reflow phenomenon following reperfusion, and diseases associated with decreased skeletal muscle blood flow. The invention also relates to pharmaceutical compositions formulated for use in such methods and to kits for such methods..
Milestone Pharmaceuticals Inc.


 Use of platelet rich plasma composition in the treatment of cardiac conduction abnormalities patent thumbnailUse of platelet rich plasma composition in the treatment of cardiac conduction abnormalities
Methods and kits for treating a cardiac arrhythmia using a platelet rich plasma (prp) composition are provided. Any type of arrhythmia may be treated using the prp composition.

 Energy delivery systems and uses thereof patent thumbnailEnergy delivery systems and uses thereof
The present invention relates to comprehensive systems, devices and methods for delivering energy to tissue for a wide variety of applications, including medical procedures (e.g., tissue ablation, resection, cautery, vascular thrombosis, treatment of cardiac arrhythmias and dysrhythmias, electrosurgery, tissue harvest, etc.). In certain embodiments, systems, devices, and methods are provided for treating a tissue region (e.g., a tumor) through application of energy..
Neuwave Medical, Inc.


 Irrigated ablation catheter patent thumbnailIrrigated ablation catheter
The present invention relates to catheters in general and more particularly to improvements in so-called “irrigated ablation catheter” that may be used in mapping and ablation procedures of tissue, preferably heart tissue in the treatment of cardiac arrhythmia. The present invention is directed irrigated ablation catheter comprising an elongated catheter shaft (4), a deflectable section (3) distal to the catheter shaft, an ablation catheter tip (1) distal to the deflectable section.
Osypka Ag


 Method of reducing the occurrence of arrhythmias via photobiomodulation and  same patent thumbnailMethod of reducing the occurrence of arrhythmias via photobiomodulation and same
In response to local or systemic inflammation in a patient, photobiomodulation therapy is applied to a cardiac location to reduce the risk and/or occurrence of cardiac arrhythmia. Once inflammation is identified, photobiomodulation therapy can be applied in any suitable fashion (e.g., via a catheter- or transesophageal probe-mounted photoemitter, via an externally-applied photoemitter, or via photoemitter incorporated into an implantable medical device).
St. Jude Medical, Atrial Fibrillation Division, Inc.


 Novel eicosanoid derivatives patent thumbnailNovel eicosanoid derivatives
That modulate conditions associated with cardiac damage, especially cardiac arrhythmias.. .

 Small loop ablation catheter patent thumbnailSmall loop ablation catheter
A catheter system for creating lesions for the treatment of cardiac arrhythmias is disclosed that includes a catheter having a distal ablation segment that has an electrode array comprising a plurality of spaced ablation and recording electrode devices arranged in a tight loop configuration that is used to create a series of overlapping loop-shaped ablation footprints to produce a continuous lesion resembling a chain-link configuration.. .

Compounds for treatment of cardiac arrhythmias

Compounds and methods thereof for reducing cardiac arrhythmia are described. In particular, compounds generated by adding chemical groups that enhance the electron donor properties of ryr inhibitors may increase inhibitor potency and thus allow for new more potent anti-arrhythmic drugs.
Baylor College Of Medicine

Methods for calibrating the administration of vanoxerine for terminating acute episodes of cardiac arrhythmia, restoring normal sinus rhythm, preventing recurrence of cardiac arrhythmia and maintaining normal sinus rhythm in mammals

Disclosed embodiments are related to methods for administering compositions of vanoxerine (gbr 12909) to patients by calibrating an effective dose for treatment of cardiac arrhythmias.. .
Laguna Pharmaceuticals , Inc.

Novel metabolites of vanoxerine compounds, pharmaceutical compositions containing the same and methods of terminating acute episodes of cardiac arrhythmia, restoring normal sinus rhythm, preventing recurrence of cardiac arrhythmia and maintaining normal sinus rhythm in mammals

Disclosed embodiments are related to pharmaceutical compositions comprising novel piperazine compounds and methods of administration of the same to a patient for termination acute episodes of cardiac arrhythmias, maintaining normal sinus rhythm, restoring normal sinus rhythm, and preventing recurrence of cardiac arrhythmia.. .
Laguna Pharmaceuticals, Inc.

Devices and methods for treating cardiovascular and metabolic disease

Some embodiments of devices and methods described herein may, among other uses, favorably cause the activation and/or deactivation vascular baroreceptors in order to achieve a desired impact on physiological condition, including but not limited to baroreflex-regulated conditions, hypertension, hypotension, nervous system disorders, metabolic disorders, cardiovascular disease, heart failure, cardiac arrhythmia, renal disease, respiratory disease, diabetes, and insulin resistance. The devices and methods may be used in concert with each other and/or other treatments, medications, interventions, or behavioral regimens, and they may also be used in concert with devices and methods that perform or assist with any combination of the following: assessing or measuring a mammal's blood pressure; assessing, measuring, or predicting the impact of the described methods and devices on the patient's condition (including blood pressure); and/or protecting the surrounding anatomy from adverse effects..

Pharmaceutical compositions containing vanoxerine and p450 inhibitors and methods of terminating acute episodes of cardiac arrhythmia, restoring normal sinus rhythm, preventing recurrence of cardiac arrhythmia and maintaining normal sinus rythym in mammals through administration of said compositions

Compositions comprising vanoxerine (gbr 12909) and a p450 inhibitor, including compositions of vanoxerine and one or more p450 inhibitors, processes for their preparation thereof, and methods of using the same for treatment of cardiac arrhythmias.. .
Laguna Pharmaceuticals, Inc.

Methods of self-administration of vanoxerine for terminating acute episodes of cardiac arrhythmia in mammals

Disclosed embodiments are related to methods of administration of vanoxerine wherein a patient, previously and successfully treated for cardiac arrhythmia with vanoxerine is prescribed a further dose for self-administration of a further dose of vanoxerine for treatment of a subsequent occurrence of cardiac arrhythmia.. .
Laguna Pharmaceuticals ,inc.

Methods of remote monitoring of self-administration of vanoxerine for terminating acute episodes of cardiac arrhythmia in mammals

Disclosed embodiments are related to methods of remotely monitoring a patient being treated for cardiac arrhythmia wherein a patient, previously and successfully treated for cardiac arrhythmia with vanoxerine is prescribed a further dose for self-administration of a further dose of vanoxerine for treatment of a subsequent occurrence of cardiac arrhythmia and instructed to remotely monitor said subsequent occurrence of cardiac arrhythmia.. .
Laguna Pharmaceuticals, Inc.

Specific binding members for ngf

Specific binding members for nerve growth factor (ngf), in particular anti-ngf antibody molecules, especially human antibody molecules, and especially those that neutralise ngf activity. Methods for using anti-ngf antibody molecules in diagnosis or treatment of ngf related disorders, including pain, asthma, chronic obstructive pulmonary disease, pulmonary fibrosis, other diseases of airway inflammation, diabetic neuropathy, cardiac arrhythmias, hiv, arthritis, psoriasis and cancer..
Medimmune Limited

A system for controlled defibrillation and ventilation

The invention is a system for providing decision-assisted critical care to a patient in medical emergency situations in an out of hospital setting. The system comprises: a ventilator comprising a pressure generator and oxygen/air delivery means; an automated external defibrillator (aed) comprising a battery and primary electrocardiogram (ecg) sensors configured as chest pads that are configured to be connected to the chest of the patient and to both sense ecg and to deliver an electric shock to the patient's heart; at least one secondary ecg sensor configured to sense ecg but not to deliver electric shock and to be connected to the body of the patient at a location other than the chest; and a controller, configured to activate or instruct a caregiver to activate, the aed and to place the chest pads on the chest of the patient upon detection of shockable cardiac arrhythmias by at least one of the at least one secondary ecg sensors..
Inovytec Medical Solutions Ltd

Wearable medical treatment device with motion/position detection

A cardiac monitoring system includes an externally wearable cardiac monitoring device; at least one cardiac sensing electrode operatively coupled to the device and configured to be disposed in proximity to a patient's skin to monitor cardiac activity of the patient; at least one accelerometer configured to generate signals indicative of patient body movement; and a microcontroller disposed in the device and configured to receive the signals indicative of patient body movement, receive one or more electrocardiogram (ecg) signals of the patient from the at least one cardiac sensing electrode, and analyze the one or more ecg signals received over a period of time to determine at least one cardiac arrhythmia condition of the patient; the device being configured to wirelessly transmit data related to the at least one cardiac arrhythmia condition and the signals indicative of patient body movement recorded over the period of time to a central server.. .
Zoll Medical Corporation

Device and treating cardiac disorders by modulating autonomic response

A method and device for modulating the autonomic nervous system adjacent a pericardial space to treat cardiac arrhythmia includes a treatment source arranged to supply a treatment medium, a catheter having an end sized for insertion into the pericardial space, a medium delivery assembly having a distal end arranged to be positioned by the catheter into the pericardium, with the distal end of the delivery assembly comprising a delivery tip arranged to extend away from the distal end of the catheter into the pericardial space. A connector operatively couples the delivery tip of the medium delivery assembly to the treatment source, and the delivery tip of the medium delivery assembly including a plurality of delivery points for delivering the treatment medium at a plurality of treatment areas within the pericardial space.
Mayo Foundation For Medical Education And Research

Novel methods for the treatment of cardiac arrhythmias

The present invention relates to the therapeutic modulation of cardiac caveolin-1 to mitigate cardiac arrhythmias.. .
United States Government As Represented By The Department Of Veterans Affairs

Systems and methods for treating cardiac arrhythmias

Systems and methods for rate-adaptive pacing are disclosed. In one illustrative embodiment, a medical device for delivering electrical stimulation to a heart may include a housing configured to be implanted on the heart or within a chamber of the heart, one or more electrodes connected to the housing, and a controller disposed within the housing.
Cardiac Pacemakers, Inc.

Sensing vector selection in a cardiac stimulus device with postural assessment

Methods, implantable medical devices and systems configured to perform analysis of captured signals from implanted electrodes to identify cardiac arrhythmias. In an illustrative embodiment, signals captured from two or more sensing vectors are analyzed, where the signals are captured with a patient in at least first and second body positions.
Cameron Health Inc.

Systems and methods for treating cardiac arrhythmias

Systems and methods for treating cardiac arrhythmias are disclosed. In one embodiment, an sicd comprises two or more electrodes, a charge storage device, and a controller operatively coupled to two or more of the electrodes and the charge storage device.
Cardiac Pacemakers, Inc.

Systems and methods for treating cardiac arrhythmias

An implantable medical device (imd) may include a housing having a proximal end and a distal end and a set of one or more electrodes connected to but spaced apart from the housing. The imd may further include a controller disposed within the housing, wherein the controller is configured to sense cardiac electrical signals, and deliver electrical stimulation pulses via the first set of one or more electrodes.
Cardiac Pacemakers, Inc.

Use of electrically conductive materials for electrophysiology

Some embodiments of the present disclosure pertain to methods of improving electrical conduction across an impaired region of a tissue (e.g., myocardial tissue) by applying an electrically conductive material (e.g., carbon nanotube fibers) across the impaired region. The electrically conductive materials can become associated with non-impaired regions of the tissue on opposite sides of the impaired region by suturing.
Texas Heart Institute

Method and automatic arrhythmia classification with confidence estimation

An arrhythmia classification system receives cardiac data from an implantable medical device, performs automatic adjudication of each cardiac arrhythmia episode indicated by the cardiac data, and generates episode data representative of information associated with the episode. The episode data include at least an episode classification resulting from the automatic adjudication of the episode and a confidence level in the episode classification.
Cardiac Pacemakers, Inc.

Detection of reduced-control cardiac zones

A method of treating cardiac arrhythmia in a heart, including (i) determining that cardiac tissue is viable but with reduced innervation; and (ii) ablating the tissue to reduce a prevalence of arrhythmia in said heart. Optionally, the determining comprises detecting portions of heart wall which lack electrical activity.
Tylerton International Inc.

Defibrillator device

A defibrillator device is provided. The defibrillator device includes a first electrode, a second electrode, a readout module, a usb interface, a voltage converter and a stimulation module.
Winbond Electronics Corp.

Methods of treating a cardiac arrhythmia by thoracoscopic production of a cox maze iii lesion set

Methods of treating a subject for a cardiac arrhythmia are provided. Aspects of the methods include thoracoscopically producing a cardiac cox maze iii set of lesions in cardiac tissue of the subject in a manner sufficient to treat the subject for the cardiac arrhythmia..
Lc Therapeutics, Inc.

Assessment of iron deposition post myocardial infarction as a marker of myocardial hemorrhage

The invention provides various methods of identifying myocardial infarction (mi) patients who have microvascular obstruction (mo), persistent microvascular obstruction (pmo), reperfusion hemorrhage, iron deposition, chronic iron deposition, and/or fat infiltration/accumulation. The invention provides various methods of identifying myocardial infarction (mi) patients who are at risk of prolonged inflammation burden in heart, adverse cardiac remodeling, electrical abnormality, mechanical abnormality, malignant cardiac arrhythmia, ischemic heart failure, and/or sudden cardiac death.

Novel biphenyl derivative and preparing same

The present invention provides novel biphenyl derivatives, isomers thereof, or pharmaceutically acceptable salts thereof, methods for preparing the same, and a pharmaceutical composition containing the same. The novel biphenyl derivatives, isomers thereof, or pharmaceutically acceptable salts thereof, as disclosed in the present invention, act as muscarinic m3 receptor antagonists, and thus are useful for the prevention or treatment of a disease selected from the group consisting of chronic obstructive pulmonary disease, asthma, irritable bowel syndrome, urinary incontinence, rhinitis, spasmodic colitis, chronic cystitis, alzheimer's disease, senile dementia, glaucoma, schizophrenia, gastroesophageal reflux disease, cardiac arrhythmia, and hyper-salivation syndromes..

Systems and methods for managing tiered tachycardia therapy

Systems and methods are provided for managing tiered tachycardia therapy. The systems and methods measure a cardiac feature of interest (foi) from a cardiac electrical signal of a heart sensed from at least one electrode of a leadless cardiac pacemaker (lpm).



Cardiac Arrhythmia topics:
  • Arrhythmia
  • Cardiac Arrhythmia
  • Arrhythmias
  • Cardiac Arrhythmias
  • Fibrillation
  • Medical Device
  • Implantable Medical Device
  • Epinephrine
  • Ventricular
  • Tachycardia
  • Atrial Fibrillation
  • Atrial Fib
  • Electrical Signal
  • Sleep Apnea
  • Rheumatoid Arthritis


  • Follow us on Twitter
    twitter icon@FreshPatents

    ###

    This listing is a sample listing of patent applications related to Cardiac Arrhythmia for is only meant as a recent sample of applications filed, not a comprehensive history. There may be associated servicemarks and trademarks related to these patents. Please check with patent attorney if you need further assistance or plan to use for business purposes. This patent data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Cardiac Arrhythmia with additional patents listed. Browse our RSS directory or Search for other possible listings.


    7.6908

    file didn't exist2768

    478994 - 0 - 51